677 related articles for article (PubMed ID: 12897244)
1. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation.
Carricaburu V; Lamia KA; Lo E; Favereaux L; Payrastre B; Cantley LC; Rameh LE
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9867-72. PubMed ID: 12897244
[TBL] [Abstract][Full Text] [Related]
2. A phosphatidylinositol 3-kinase/Akt/mTOR pathway mediates and PTEN antagonizes tumor necrosis factor inhibition of insulin signaling through insulin receptor substrate-1.
Ozes ON; Akca H; Mayo LD; Gustin JA; Maehama T; Dixon JE; Donner DB
Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4640-5. PubMed ID: 11287630
[TBL] [Abstract][Full Text] [Related]
3. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling.
Li H; Marshall AJ
Cell Signal; 2015 Sep; 27(9):1789-98. PubMed ID: 26022180
[TBL] [Abstract][Full Text] [Related]
5. Serum withdrawal-induced accumulation of phosphoinositide 3-kinase lipids in differentiating 3T3-L6 myoblasts: distinct roles for Ship2 and PTEN.
Mandl A; Sarkes D; Carricaburu V; Jung V; Rameh L
Mol Cell Biol; 2007 Dec; 27(23):8098-112. PubMed ID: 17893321
[TBL] [Abstract][Full Text] [Related]
6. PIP4Ks Suppress Insulin Signaling through a Catalytic-Independent Mechanism.
Wang DG; Paddock MN; Lundquist MR; Sun JY; Mashadova O; Amadiume S; Bumpus TW; Hodakoski C; Hopkins BD; Fine M; Hill A; Yang TJ; Baskin JM; Dow LE; Cantley LC
Cell Rep; 2019 May; 27(7):1991-2001.e5. PubMed ID: 31091439
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
8. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin.
Blero D; De Smedt F; Pesesse X; Paternotte N; Moreau C; Payrastre B; Erneux C
Biochem Biophys Res Commun; 2001 Apr; 282(3):839-43. PubMed ID: 11401540
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 5 Phosphate 4-Kinase Regulates Plasma-Membrane PIP
Sharma S; Mathre S; Ramya V; Shinde D; Raghu P
Cell Rep; 2019 May; 27(7):1979-1990.e7. PubMed ID: 31091438
[TBL] [Abstract][Full Text] [Related]
10. Constitutive activation of protein kinase B and phosphorylation of p47phox by a membrane-targeted phosphoinositide 3-kinase.
Didichenko SA; Tilton B; Hemmings BA; Ballmer-Hofer K; Thelen M
Curr Biol; 1996 Oct; 6(10):1271-8. PubMed ID: 8939574
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase B (PKB/Akt) activity is elevated in glioblastoma cells due to mutation of the tumor suppressor PTEN/MMAC.
Haas-Kogan D; Shalev N; Wong M; Mills G; Yount G; Stokoe D
Curr Biol; 1998 Oct; 8(21):1195-8. PubMed ID: 9799739
[TBL] [Abstract][Full Text] [Related]
12. The type Ialpha inositol polyphosphate 4-phosphatase generates and terminates phosphoinositide 3-kinase signals on endosomes and the plasma membrane.
Ivetac I; Munday AD; Kisseleva MV; Zhang XM; Luff S; Tiganis T; Whisstock JC; Rowe T; Majerus PW; Mitchell CA
Mol Biol Cell; 2005 May; 16(5):2218-33. PubMed ID: 15716355
[TBL] [Abstract][Full Text] [Related]
13. Membrane localization of Src homology 2-containing inositol 5'-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors.
Ishihara H; Sasaoka T; Ishiki M; Wada T; Hori H; Kagawa S; Kobayashi M
Mol Endocrinol; 2002 Oct; 16(10):2371-81. PubMed ID: 12351701
[TBL] [Abstract][Full Text] [Related]
14. Impact of Src homology 2-containing inositol 5'-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acids.
Murakami S; Sasaoka T; Wada T; Fukui K; Nagira K; Ishihara H; Usui I; Kobayashi M
Endocrinology; 2004 Jul; 145(7):3215-23. PubMed ID: 15044364
[TBL] [Abstract][Full Text] [Related]
15. Shigella flexneri infection generates the lipid PI5P to alter endocytosis and prevent termination of EGFR signaling.
Ramel D; Lagarrigue F; Pons V; Mounier J; Dupuis-Coronas S; Chicanne G; Sansonetti PJ; Gaits-Iacovoni F; Tronchère H; Payrastre B
Sci Signal; 2011 Sep; 4(191):ra61. PubMed ID: 21934107
[TBL] [Abstract][Full Text] [Related]
16. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt.
Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL
Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057
[TBL] [Abstract][Full Text] [Related]
17. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
[TBL] [Abstract][Full Text] [Related]
18. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
[TBL] [Abstract][Full Text] [Related]
19. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Reed DE; Shokat KM
Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
[TBL] [Abstract][Full Text] [Related]
20. PtdIns5P activates the host cell PI3-kinase/Akt pathway during Shigella flexneri infection.
Pendaries C; Tronchère H; Arbibe L; Mounier J; Gozani O; Cantley L; Fry MJ; Gaits-Iacovoni F; Sansonetti PJ; Payrastre B
EMBO J; 2006 Mar; 25(5):1024-34. PubMed ID: 16482216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
